- CharmHealth Elevates Patient Care With Charm AI Scribe
- Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment
- RenyMed Earns Prestigious EcoVadis Gold Medal for Excellence in Sustainability
- The Role of Contract Research Organizations in Modern Clinical Research
- Michael Andersen Joins Vektor Medical as Vice President, Quality Assurance and Regulatory Affairs
- Bracco Diagnostics Announces Significant Upgrades to its Innovative HeartSee™ Software
- SubtleHD Receives CE Mark, Expanding Access to AI-Powered MRI Enhancement Across Europe Reports Subtle Medical
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors.
Stay Ahead in Medical Technology
At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.
In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.
Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.
Stay informed, stay connected, and join us as we navigate the future of healthcare together.
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
CMS Establishes HCPCS code for Ultromics EchoGo ® Heart Failure, Accelerating Access to Precision HFpEF Detection
Ultromics EchoGo ® Heart Failure is the first US Food and Drug Administration (FDA) cleared platform for detecting Heart Failure with Preserved Ejection Fraction (HFpEF), using a single view of an echocardiogram. The platform has the potential to catch disease earlier and get more patients on the pathway to treatment.
CPR Therapeutics Inc. Receives Three Patents In One Week For Innovations In Cardiopulmonary Resuscitation Technology
Norman Paradis MD, CPR Therapeutics Founder and CEO stated: “Receiving all three patents in one week is a wonderful coincidence that highlights the breadth of our innovation. We already knew that our existing patent portfolio was strong and provided a sound foundation for our future commercial efforts. Now it is even stronger. I believe any one of these patents could justifiably be called a breakthrough invention in and of itself.”
Medical Syringe: The Alternatives With High-Quality Materials
Medical syringes are indispensable tools in healthcare settings, facilitating the safe and precise administration of medications, vaccines, and other substances. Traditionally made from glass or
Medovate Signs First Distributor Agreement for its Pioneering SAFIRA® Technology in the Veterinary Field with 20/20 Imaging in the USA
Bob Salzman, President 20/20 Imaging said: “This is a ground-breaking new technology for safer regional anesthesia and is unique in making it a one person procedure and reducing reliance on subjective ‘injection pressure feel’. 20/20 Imaging are proud to be the first appointed distributor to be bringing its unique benefits to the veterinary market and we look forward to making this exciting technology available to veterinary professionals across America alongside our leading range of ultrasound solutions to enable them to deliver the best care for their patients.”
Clinical Trials
First Multi-Center Study Combining the Allurion Program With GLP-1 Therapy Presented at the European Congress on Obesity
The retrospective study was conducted across 3 obesity centers in Italy, Spain and Egypt. In total, 181 patients with BMIs of 27 and above were enrolled in the Allurion Program with Saxenda® (liraglutide) added once daily starting 4 to 16 weeks after balloon placement. On average, the duration of drug treatment was just over 4 months (4.1 ± 2.2 months).
EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
DynamX Bioadaptor is a new type of coronary implant designed to unlock the scaffold, uncage the vessel, to return normal vessel motion and function after percutaneous coronary intervention (PCI), with continued dynamic support of the atherosclerotic vessel to reduce long-term adverse events. In the study, the bioadaptor demonstrated superior effectiveness of its unique mechanism of action across secondary intravascular imaging endpoints, achieving restoration of the vessel motion and function compared to persistent constraint with DES.
Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea
The nausea study revealed how nausea can affect daily life in many unpleasant ways. More than 18% of respondents reported that their nausea actively hindered their ability to travel, while some could not socialize (3.2%) or even work (2.9%). These findings highlight how nausea extends beyond mere inconvenience for a large majority of the U.S. population.
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Why Healthcare Professionals are Leaving Corporate Hospitals and Healthcare Systems to Start Their Own Businesses
Over the past few years, doctors and other healthcare professionals have been pushed to their limits. Reports show that between 25 and 30 percent of healthcare professionals suffer from symptoms of burnout. According to one study, one in five doctors have said they plan to quit in the next two years. Duprat sets examples! Read on to learn more.
How a Governance Council Elevates Clinical Asset Management
Creating a governance council for medical device management is one of the most prudent things a hospital can do, particularly with such a pressing need to rein in expenses. About a quarter of health system capital expenditures are spent on medical equipment on average. A governance council serves as an agent of change in how a health system manages its clinical assets, but as we all know, change can be challenging. Read on.
Ashish Kachru, CEO of DataLink Writes: “Value-Based Technology Platform Increases HCC Recapture Rate Over 80% for Large Network Provider Groups”
As a growing number of providers shift toward value-based payment models, they are adopting. Hierarchical Condition Category coding – a risk-adjustment model originally designed to estimate future health care costs for patients. Read what Ashish Kachru, CEO, DataLink highlights in his article.
Executives on the Move
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Market Reports
Advancements In Imaging
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare: Understanding the Business Side of the Industry and Its Implications
7 Best Healthcare and Medical Business Ideas In 2021
Healthcare and Medical Business Ideas The healthcare industry is a broad and lucrative market that consists of sectors like clinical services, medical equipment, the manufacture
Telehealth is Only as Good as the Bandwidth in Many Critical Cases
On Telehealth: Timothy Kelley, CEO of Nautilus, said “Our rural and mobile doctors and professionals can use TeleRay in many situations.” He explained that TeleRay could view modalities such as ultrasound in real-time from remote locations.
